Renaissance Technologies (RenTech)'s CVS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 263,153 shares of CVS Health Corporation (CVS) worth $18.9 M, representing 0.03% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 3.65 M shares. Largest reduction occurred in Q2 2023, reducing 3.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +263,153 | New Buy | 263,153 | $71.82 |
| Q4 2025 | -160,900 | Sold Out | 0 | $0.00 |
| Q3 2025 | -421,953 | Reduce 72.39% | 160,900 | $75.39 |
| Q2 2025 | +532,853 | Add 1065.71% | 582,853 | $68.98 |
| Q1 2025 | +50,000 | New Buy | 50,000 | $67.75 |
| Q4 2024 | -967,153 | Sold Out | 0 | $0.00 |
| Q3 2024 | +967,153 | New Buy | 967,153 | $62.88 |
| Q1 2024 | -628,353 | Sold Out | 0 | $0.00 |
| Q4 2023 | +628,353 | New Buy | 628,353 | $78.96 |
| Q3 2023 | -1.43 M | Sold Out | 0 | $0.00 |
| Q2 2023 | -3.64 M | Reduce 71.88% | 1.43 M | $0.07 |
| Q1 2023 | +2.51 M | Add 97.93% | 5.07 M | $0.07 |
| Q4 2022 | +715,600 | Add 38.77% | 2.56 M | $0.09 |
| Q3 2022 | -308,819 | Reduce 14.33% | 1.85 M | $95.37 |
| Q2 2022 | +1.38 M | Add 178.09% | 2.15 M | $92.66 |
| Q1 2022 | +586,919 | Add 312.36% | 774,819 | $101.21 |
| Q4 2021 | -126,472 | Reduce 40.23% | 187,900 | $103.16 |
| Q3 2021 | -1.23 M | Reduce 79.60% | 314,372 | $84.86 |
| Q2 2021 | -250,358 | Reduce 13.98% | 1.54 M | $83.44 |
| Q1 2021 | +1.79 M | New Buy | 1.79 M | $75.23 |
| Q4 2020 | -1.82 M | Sold Out | 0 | $0.00 |
| Q3 2020 | +739,739 | Add 68.55% | 1.82 M | $58.40 |
| Q2 2020 | -192,069 | Reduce 15.11% | 1.08 M | $64.97 |
| Q1 2020 | +1.26 M | Add 9639.16% | 1.27 M | $59.33 |
| Q4 2019 | -386,215 | Reduce 96.73% | 13,053 | $74.31 |
| Q3 2019 | +196,615 | Add 97.02% | 399,268 | $63.07 |
| Q2 2019 | -100,900 | Reduce 33.24% | 202,653 | $54.49 |
| Q1 2019 | -1.02 M | Reduce 77.06% | 303,553 | $53.93 |
| Q4 2018 | +1.32 M | New Buy | 1.32 M | $65.52 |
| Q2 2018 | -1.92 M | Sold Out | 0 | $0.00 |
| Q1 2018 | +30,800 | Add 1.63% | 1.92 M | $62.21 |
| Q4 2017 | +1.89 M | New Buy | 1.89 M | $72.50 |
| Q2 2017 | -1.41 M | Sold Out | 0 | $0.00 |
| Q1 2017 | +689,500 | Add 95.17% | 1.41 M | $78.50 |
| Q4 2016 | -215,500 | Reduce 22.93% | 724,505 | $78.91 |
| Q3 2016 | -2.9 M | Reduce 75.53% | 940,005 | $88.99 |
| Q2 2016 | +3.65 M | Add 1869.25% | 3.84 M | $95.74 |
| Q1 2016 | +195,105 | New Buy | 195,105 | $103.73 |
| Q4 2015 | -854,505 | Sold Out | 0 | $0.00 |
| Q3 2015 | +854,505 | New Buy | 854,505 | $96.48 |
| Q4 2013 | -480,305 | Sold Out | 0 | $0.00 |
| Q3 2013 | +480,305 | New Buy | 480,305 | $56.75 |
Renaissance Technologies (RenTech)'s CVS Health Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased CVS Health Corporation (CVS) in Q3 2013, acquiring 480,305 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held CVS Health Corporation (CVS) for 42 quarters since Q3 2013.
Renaissance Technologies (RenTech)'s largest addition to CVS Health Corporation (CVS) was in Q2 2016, adding 3,842,105 shares worth $367.84 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 263,153 shares of CVS Health Corporation (CVS), valued at approximately $18.9 M.
As of the Q1 2026 filing, CVS Health Corporation (CVS) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in CVS Health Corporation (CVS) was 5,069,953 shares, as reported at the end of Q1 2023.